Tratamiento farmacológico de la obesidad|505
18.
Novelli L L, Ribas Ozonas B y Novelli E L B (2005) Metais: Aspectos da Toxicidade.
Nutriçao e Vida Saudavel, Capítulo 18, 235-‐240. Editor: E.L.B. Novelli. Tecmedd
Editora, Sao Paulo, Brasil.
19.
OMS. Nota descriptiva nº 311.
OMS, mayo de 2012.
20.
O’Neil P et al. (2012) Random
o-‐controlled clinical trial of lorcaserin for
weight loss in type 2 diabetes mellitus: the Bloom-‐DM study. Obesity 20 (7): 1426-‐
1436.
21.
Ribas Ozonas B, Dean Guelbenzu M and Santos Ruiz A. (1970) Inhibitory effect of
cadmium on alkaline phosphatase of kidney and prostate of guinea pig. Editor: C F
Mills. Editorial: E S Livingstone, Edimburgh and London, I, 173-‐176.
22.
Ribas Ozonas B (1991) Lithium (Review). In: Metal and Their Compounds in the
Environment. (E. Merian, edt. vol II, Chap. 17, 1015-‐1023. VCH Verlag, Weinheim,
Germany.
23.
Ribas B, Castro MD, García Arribas O, Pérez Calvo M, Santos Ruiz A, Novelli ELB y
Núñez M (2001) Metalotioneínas y Medio Ambiente. Editor: Pablo Gil-‐Loyzaga,
Tomo I 341-‐349. Fundación General de la Universidad Complutense y
Ayuntamiento de Madrid.
24.
Ribas Ozonas B. (2004) Metallothioneins. (Review) In: Elements and their
compounds in the Environment. Eds: M E, Merian, M Anke, M Ihnat and M
Stoeppler. Editorial: Wiley-‐VCH, Germany. Volume 1, Part 2 Chapter 6, 391-‐400.
25.
Ribas Ozonas B. (2010) Metalotioneína y algunos elementos minerales como
bioindicadores en toxicologia clínica. En: Biomarcadores: Analítica, Diagnóstico y
Terapéutica. (Editor: F. Ortega Ruiz de Apodaca). Capítulo 8. Real Academia
Nacional de Farmacia. Monografía XXX. Editorial: Realigraf, S.A. Madrid, 259-‐312.
26.
Rink D, Roy S, Khanna S, Rink T, Bagchi D and Sen, CK. (2006) Transcriptome of the
subcutaneous adipose tissue in response to oral supplementation of type 2 Leprdb
obese diabetic mice with niacin-‐bound chromium. Physiol Genomics. 27: 370-‐379.
27.
Rubio Herrera MA y Moreno Lopera C (2013) Tratamiento farmacológico de la
obesidad. Endocrinol Nutr 60 (Supl 1), 19-‐22.
28.
Sato M y cols. (2910) Development of high-‐fat-‐diet-‐induced obesity in female
metallothionein-‐null mice. FASEB J 24 (7), 2375-‐2384.
29.
Serrano-‐Rios M (2007) La pandemia de obesidad y sus consecuencias metabólicas.
Discurso. Real Academia Nacional de Medicina. Madrid.
30.
Van Itallie TB and. Simopoulos AP (eds.) (1995) Obesity New Directions in
Assessment and Management. Copyright by the Charles Press, Publishers, Inc.
31.
WHO. (1998) Obesity. Preventing and managing the global epidemic. Report of a
WHO consultation on obesity. Ginebra: WHO, 1998.
32.
Wynne K, Stanley S, McGowan B, Bloom S. (2005) Appetite control. J Endocrinol.
184: 291-‐318.
